Enhancing the site-specific targeting of macromolecular anticancer drug delivery systems

Current Drug Targets

Volumn 7, Issue 2, 2006, Pages 229-235

  Neerman, Michael F ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Antibodies; Anticancer; Drug delivery; Folic acid; Hyaluronic acid; Macromolecules; RGD; Targeting

Indexed keywords

ALBUMIN; ANTIBODY; ANTINEOPLASTIC AGENT; ARGININE; ASPARTIC ACID; DAUNORUBICIN; DENDRIMER; DOXORUBICIN; DRUG VEHICLE; FENRETINIDE; FLUOROURACIL; FOLATE RECEPTOR; FOLIC ACID; GLYCINE; INTEGRIN RECEPTOR; LIPOSOME; METHOTREXATE; MITOMYCIN C; PACLITAXEL; POLYMER; DRUG CARRIER; INTEGRIN;

ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; BRAIN CANCER; BREAST CANCER; CANCER; CANCER CELL; CARDIOTOXICITY; CLINICAL TRIAL; COLON CANCER; CYTOTOXICITY; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG TARGETING; DRUG TOLERABILITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MICELLE; NONHUMAN; NOSE CANCER; OVARY CANCER; PHARYNX CANCER; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; TUMOR XENOGRAFT; ANIMAL; BINDING SITE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; MACROMOLECULE; METABOLISM; NEOPLASM; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BINDING SITES; CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; HUMANS; INTEGRINS; MACROMOLECULAR SUBSTANCES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; NEOPLASMS;

EID: 33644863209     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945006775515473     Document Type: Review

References (85)

1. Ringsdorf, H. (1975) J. Polym. Sci. Symp. 51, 135-153.
2. Lu, Z.R.; Shiah, J.G.; Sakuma, S.; Kopeckova, P. and Kopecek, J. (2002) J. Control Release 78, 165-173.
3. Duncan, R. (2003) Nat. Rev. Drug Discovery 2, 347-360.
4. Vasir, J.K. and Labhasetwar, V. (2005) Technol. Cancer Res. Treat. 4(4), 363-74.
5. Jain, K.K. (2005) Technol. Cancer Res. Treat. 4(4), 407-416.
6. Maeda, H.; Seymour, L.W. and Miyamoto, Y. (1992) Bioconjug. Chem. 3, 351-362.
7. Greish, K.; Fang, J.; Inutsuka, T.; Nagamitsu, A. and Maeda H. (2003) Clin. Pharmacokinet. 42(13), 1089-1105.
8. Mehvar, R. (2003) Curr. Pharm. Biotechnol. 4(5), 283-302.
9. Luo, Y. and Prestwich, G.D. (2002) Curr. Cancer Drug Targets 2(3), 209-226.
10. Nori, A. and Kopecek, J. (2005) Adv. Drug Deliv. Rev. 57(4), 609-636.
11. Neerman, M.F.; Chen, H.-T.; Parrish, A.R. and Simanek, E.E. (2004) Molec. Pharm. 1(5), 390-393.
12. Dvorak, J.; Zoul, Z.; Melichar, B.; Peters, J.; Vesely, P.; Vosmik, M. and Dolezel, M. (2004) J. Chemother. 16(5), 34-36.
13. Boulikas, T. (2004) Oncol. Rep. 12(1), 3-12.
14. Ruoslahti, E. and Rajotte, D. (2000) Annu. Rev. Immunol. 18, 813-827.
15. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y. and Hori, K. (2000) J. Control Release 65, 271-284.
16. Maeda, H.; Fang, J.; Inutsuka, T. and Kitamoto, Y. (2003) Int. Immunopharmacol. 3, 319-328.
17. Duncan, R. (1992) Anti-cancer Drugs 3, 175-210.
18. Panyam, J. and Labhasetwar, V. (2003) Pharm. Res. 20, 212-220.
19. Hopkins, C. and Trowbridge, I.S. (1983) J. Cell Biol. 97, 508-521.
20. Trowbridge, I.S. and Domingo, D.L. (1981) Nature 294, 171-173.
21. De Smidt, P.C. and Van Berkel, T.J. (1990) CRC Crit. Rev. Ther. Drug Carrier Syst. 7, 99-120.
22. Gupta, P.K. and Hung, C.T. (1989) J. Microencapsul. 6, 427-462.
23. Gupta, P.K. and Hung, C.T. (1989) J. Microencapsul. 6, 463-472.
24. Chuang, V.T.; Kragh-Hansen, U. and Otagiri, M. (2002) Pharm. Res. 19(5), 569-577.
25. Mainardes, R.M. and Silva, L.P. (2004) Curr. Drug Targets 5, 449-455.
26. Medina, O.P.; Zhu, Y. and Kairemo, K. (2004) Curr. Pharm. Des. 10, 2981-2989.
27. Goyal, P.; Goyal, K.; Kumar, S.G.; Singh, A.; Katare, O.P. and Mishra, D.N. (2005) Acta Pharm. 55(1), 1-25.
28. Bat, H.G. (1977) Adv. Polym. Sci. 23, 5-53.
29. Vert, M. (1986) CRC Crit. Rev. Ther. Drug Carrier Syst. 2, 291-327.
30. Pillai, O. and Panchagnula, R. (2001) Curr. Opin. Chem. Biol. 5, 447-451.
31. Liu, M. and Fréchet J.M. (1999) Pharm. Sci. Technol. Today 2(10), 393-401.
32. Patri, A.K.; Majoros, I.J. and Baker J.R. (2002) Curr. Opin. Chem. Biol. 6(4), 466-471.
33. Boas, U. and Heegaard, P.M. (2004) Chem. Soc. Rev. 33(1), 43-63.
34. Gillies, E.R. and Fréchet, J.M. (2005) Drug Discov. Today 10(1), 35-43.
35. Antony, A.C. (1992) Blood 79, 2807-2820.
36. Kamen, B.A. and Capdevila (1986) Proc. Natl. Acad. Sci. USA 83, 5983-5987.
37. Campbell, I.G.; Jones, T.A.; Foulkes, W.D. and Trowsdale, J. (1991) Cancer Res. 51, 5329-5338.
38. Weitman, S.D.; Lark, R.H.; Coney, L.R.; Fort, D.W.; Frasca, V.; Zurawski, V.R. Jr. and Kamen, B.A. (1992) Cancer Res. 52, 3396-3401.
39. Weitman, S.D.; Frazier, K.M. and Kamen, B.A. (1994) J. Neuro-Oncol. Oncol. 21, 107-112.
40. Toffoli, G.; Cernigoi, C.; Russo, A.; Gallo, A.; Bagnoli, M. and Boiocchi, M. (1997) Int. J. Cancer 74, 193-198.
41. Bueno, R.; Appasani, K.; Mercer, H.; Lester, S. and Sugarbaker, D. (2001) J. Thorac. Cardiovasc. Surg. 121(2), 225-233.
42. Mattes, M.J.; Major, P.P.; Goldenberg, D.M.; Dion, A,S.; Hutter, R.V. and Klein K.M. (1990) Cancer Res. 50(3) 880S-884S.
43. Holm J.; Hansen, S.I.; Hoier-Madsen, M. and Bostad, L. (1991) Biochem. J. 280(Pt. 1), 267-271.
44. Ross J.F.; Chaudhuri, P.K. and Ratnam, M. (1994) Cancer 73, 2432-2443.
45. Pan, X.Q. and Lee, R.J. (2005) Anticancer Res. 25(1A), 343-346.
46. Stevens, P.J.; Sekido, M. and Lee, R.J. (2004) Pharm. Res. 21(12), 2153-2157.
47. Turk, M.J.;, Waters, D.J. and Low, P.S. (2004) Cancer Lett. 213(2), 165-172.
48. Yoo, H.S. and Park, T.G. (2004) J. Control Release. 100(2), 247-256.
49. Kukowska-Latallo, J.F.; Candido, K.A.; Cao, Z.; Nigavekar, S.S.; Majoros, I.J.; Thomas, T.P.; Balogh, L.P.; Khan, M.K.; Baker, J.R. Jr. (2005) Cancer Res. 65(12), 5317-5324.
50. Shukla, S.; Wu, G.; Chatterjee, M.; Yang, W.; Sekido, M.; Diop, L.A.; Muller, R.; Sudimack, J.J.; Lee, R.J.; Barth, R.F. and Tjarks, W. (2003) Bioconjug. Chem. 14(1), 158-167.
51. Ruoslahti, E. (1996) Annu. Rev. Cell. Dev. Biol. 12, 697-715.
52. Hart, S.L.; Knight, A.M.; Harbottle, R.P.; Mistry, A.; Hunger, H.D.; Cutler, D.F.; Williamson, R. and Coutelle, C. (1994) J. Biol. Chem. 269, 12468-12474.
53. Schiffelers, R.M.; Koning, G.A.; ten Hagen, T.L.; Fens, M.H.; Schraa, A.J.; Janssen, A.P.; Kok, R.J.; Molema, G. and Storm, G. (2003) J. Control Release 91(1-2), 115-22.
54. Dubey, P.K.; Mishra, V.; Jain, S.; Mahor, S. and Vyas, S.P. (2004) J. Drug Target. 12(5), 257-264.
55. Xiong, X.B.; Huang, Y.; Lu, W.L.; Zhang, X.; Zhang, H.; Nagai, T. and Zhang, Q. (2005) J. Pharm. Sci. 94(8), 1782-1793.
56. Pattillo, C.B.; Sari-Sarraf, F.; Nallamothu, R.; Moore, B.M.; Wood, G.C. and Kiani, M.F. (2005) Pharm. Res. 22(7), 1117-1120.
57. Mitra, A.; Mulholland, J.; Nan, A.; McNeill, E.; Ghandehari, H. and Line, B.R. (2005) J. Control Relese 102(1), 191-201.
58. Chari, R.V.J.; Jackel, K.A.; Bourret, L.A.; Derr, S.M.; Tadayoni, B.M.; Mattocks, K.M.; Shah, S.A.; Liu, C.N.; Blattler, W.A. and Goldmacher, V.S. (1995) Cancer Res. 55, 4079-4084.
59. Park, J.W.; Hong, K.; Kirpotin, D.B.; Papahadjopoulos, D. and Benz, C.C. (1997) Adv. Pharmacol. 40, 399-435.
60. Park, J.W.; Hong, K.; Kirpotin, D.B.; Meyer, O.; Papahadjopoulos, D. and Benz, C.C. (1997) Cancer Lett. 118(2), 153-160.
61. Park, J.W.; Kirpotin, D.B.; Hong, K.; Shalaby, R.; Shao, Y.; Nielsen, U.B.; Marks, J.D.; Papahadjopoulos, D. and Benz, C.C. (2001) J. Control Release 74(1-3), 95-113.
62. Park, J.W.; Hong, K.; Kirpotin, D.B.; Colbern, G.; Shalaby, R.; Baselga, J.; Shao, Y.; Nielsen, U.B.; Marks, J.D.; Moore, D.; Papahadjopoulos, D. and Benz, (2002) Clin. Cancer Res. 8(4), 1172-1181.
63. Chekhonin, V.P.; Zhirkov, Y.A.; Gurina, O.I.; Ryabukhin, I.A.; Lebedev, S.V.; Kashparov, I.A. and Dmitriyeva, T.B. (2005) Drug Deliv. 12(1), 1-6.
64. Raffaghello, L,; Pagnan, G.; Pastorino, F.; Cosimo, E.; Brignole, C.; Marimpietri, D.; Bogenmann, E.; Ponzoni. M. and Montaldo, P.G. (2003) Cancer Lett. 197(1-2), 151-155.
65. Matsumura, Y.; Gotoh, M.; Muro, K.; Yamada, Y.; Shirao, K.; Shimada, Y.; Okuwa, M.; Matsumoto, S.; Miyata, Y.; Ohkura, H.; Chin, K.; Baba, S.; Yamao, T.; Kannami, A.; Takamatsu, Y.; Ito, K. and Takahashi, K. (2004) Ann. Oncol. 15, 517-525.
66. Hosokawa, S.; Tagawa, T.; Niki, H.; Hirakawa, Y.; Nohga, K. and Nagaike, K. (2003) Br. J. Cancer 89, 1545-1551.
67. Gao, Z.; Lukyanov, A.N.; Chakilam, A.R. and Torchilin, V.P. (2003) J. Drug Target 11(2), 87-92.
68. Torchilin, V.P.; Lukyanov, A.N.; Gao, Z. and Papahadjopoulos-Sternberg, B. (2003) Proc. Natl. Acad. Sci. USA 100(10), 6039-6044.
69. Thomas, T.P.; Patri, A.K.; Myc, A.; Myaing, M.T.; Ye, J.Y.; Norris, T.B.; Baker, J.R. Jr. (2004) Biomacromolecules 5(6), 2269-2274.
70. Patri, A.K.; Myc, A.; Beals, J.; Thomas, T.P.; Bander, N.H. and Baker, J.R. Jr. (2004) Bioconjug. Chem. 15(6), 1174-1181.
71. Dea, I.C.; Moorhouse, R.; Rees, D.A.; Arnott, S.; Guss, J.M. and Balazs, E.A. (1973) Science 179(73), 560-562.
72. Jaracz, S.; Chen, J.; Kuznetsova, L.V. and Ojima, I. (2005) Bioorg. Med. Chem. (2005) 13(17), 5043-5054.
73. Huang, L.; Grammatikakis, N.; Yoneda, M.; Banerjee, S.D. and Toole, B.P. (2000) J. Biol. Chem. 275, 29829-29839.
74. Ponta, H.; Sherman, L. and Herrlich, P.A. (2003) Nat. Rev. Mol. Cell Biol. 4, 33-45.
75. Toole, B.P.; Wight, T.N. and Tammi, M.I. (2002) J. Biol. Chem. 277, 4593-4596.
76. Yang, B.; Zhang, L. and Turley, E.A. (1993) J. Biol. Chem. 268, 8617-8623.
77. McBride, W.H. and Bard, J.B. (1979) J. Exp. Med. 149(2), 507-515.
78. Day, A.J. and Prestwich, G.D. (2002) J. Biol. Chem. 277(7), 4585-4588.
79. Turley, E.A.; Belch, A.J.; Poppema, S. and Pilarski, L.M. (1993) Blood 81(2), 446-453.
80. Yerushalmi, N. and Margalit, R. (1998) Arch. Biochem. Biophys. 349(1), 21-26.
81. Eliaz, R.E. and Szoka, F.C. Jr. (2001) Cancer Res. 61(6), 2592-2601.
82. Eliaz, R.E.; Nir, S. and Szoka, F.C. Jr. (2004) Methods Enzymol. 387, 16-33.
83. Peer, D. and Margalit, R. (2004) Int. J. Cancer 108(5), 780-789.
84. Peer, D. and Margalit, R. (2004) Neoplasia 6(4), 343-353.
85. Luo, Y.; Bernshaw, N.J.; Lu, Z.R.; Kopecek, J. and Prestwich, G.D. (2002) Pharm. Res. 19(4), 396-402.